Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Rev. otorrinolaringol. cir. cabeza cuello ; 82(2): 190-194, jun. 2022. ilus
Article in Spanish | LILACS | ID: biblio-1389855

ABSTRACT

Resumen El plasmocitoma extramedular es una neoplasia de células plasmáticas poco frecuente, que se ubica en 80% a 90% de los casos en la cabeza o cuello. Esta neoplasia representa menos del 1% de toda la patología maligna de cabeza y cuello. Dada la poca frecuencia de la patología y la escasez de casos publicados, esta entidad presenta una gran dificultad clínica y terapéutica. El diagnóstico se basa en el análisis histológico con inmunohistoquímica de la muestra obtenida, y el tratamiento varía según la ubicación, donde se puede realizar radioterapia o cirugía. En este artículo presentamos el caso de una paciente de 56 años, con antecedentes de otorrea de larga data en oído derecho, al examen físico presentaba un tumor que obstruía todo el conducto auditivo externo. Se realizó exéresis tumoral y la biopsia evidenció un plasmocitoma.


Abstract Extramedullary plasmacytoma is a rare plasma cell neoplasm, affecting 80% to 90% of the head or neck. This neoplasm represents less than 1% of all malignant head and neck pathology. Given the infrequency of the pathology and the scarcity of published cases, this entity presents great clinical and therapeutic difficulty. Diagnosis is based on histology and immunohistochemistry and treatment varies depending on the location, where radiation therapy or surgery can be performed. In this article, we present the case of a 56-year-old patient with a history of long-standing otorrhea in the right ear. Physical examination presented a tumor that obstructed the entire external auditory canal. Tumor excision was performed, and the biopsy revealed a plasmacytoma.


Subject(s)
Humans , Female , Middle Aged , Plasmacytoma/surgery , Plasmacytoma/pathology , Plasmacytoma/diagnostic imaging , Ear Neoplasms/surgery , Ear Neoplasms/pathology , Ear Neoplasms/diagnostic imaging , Plasma Cells , Magnetic Resonance Spectroscopy , Tomography, X-Ray Computed , Diagnosis, Differential , Ear , Ear Canal
2.
Rev. Soc. Odontol. La Plata ; 31(60): 23-26, jul. 2021. ilus
Article in Spanish | LILACS | ID: biblio-1284468

ABSTRACT

Las neoplasias malignas de la cavidad oral en gran medida (90%) consisten en carcinoma de células escamosas que surgen de la mucosa de revestimiento. El 10% restantes de neoplasias malignas orales de un grupo heterogéneo de tumores de diferente etiología. Presentamos dos casos de patología oncohematológica: Mieloma Múltiple (AU)


Malignant neoplasms of the oral cavity largely (90%) consist of squamous cell carcinoma arising from the lining mucosa. e remaining 10% of oral malignancies from a heterogeneous group of tumors of different etiology. We present two cases of oncohematological pathology: Multiple Myeloma (AU)


Subject(s)
Humans , Male , Middle Aged , Plasmacytoma/diagnosis , Plasmacytoma/pathology , Plasmacytoma/diagnostic imaging , Mouth Neoplasms/diagnosis , Radiotherapy , Biopsy/methods , Tomography, X-Ray Computed , Oral Surgical Procedures/methods , Diphosphonates/therapeutic use , Maxillary Sinus/surgery , Multiple Myeloma
3.
Arq. bras. neurocir ; 40(2): 159-161, 15/06/2021.
Article in English | LILACS | ID: biblio-1362223

ABSTRACT

Sellar plasmacytomas are rare tumors arising from plasma cells. They are often misdiagnosed as adenomas.We report the case of a 63-year-old woman with headache, cranial nerve III palsy and decreased visual acuity. Imaging revealed an extensive lesion centered on the clivus, extending to the cavernous sinus bilaterally and into the sphenoid sinus. The hormonal tests were compatible with panhypopituitarism and mild hyperprolactinemia. The first hypothesis was invasive pituitary adenoma. Partial resection was achieved, and the immunohistochemical evaluation was compatible with plasmacytoma. After a few weeks, she developed lumbar and hip pain, and the imaging confirming osteolytic lesions. The final diagnosis was multiple myeloma.


Subject(s)
Humans , Female , Middle Aged , Pituitary Neoplasms/therapy , Plasmacytoma/surgery , Multiple Myeloma/diagnosis , Multiple Myeloma/pathology , Pituitary Neoplasms/diagnostic imaging , Plasmacytoma/pathology , Plasmacytoma/diagnostic imaging , Adenoma/pathology , Diagnosis, Differential , Multiple Myeloma/surgery
4.
Rev. cir. (Impr.) ; 71(4): 341-344, ago. 2019. ilus
Article in Spanish | LILACS | ID: biblio-1058282

ABSTRACT

Resumen Introducción: El 50% de los tumores de pared torácica son malignos, dentro de los que destaca el plasmocitoma de costilla. Objetivo: Presentar un caso clínico que debutó inicialmente como un plasmocitoma de costilla, y que terminó presentándose como mieloma múltiple. Materiales y Método: Registro clínico de un paciente sometido a resección de tumor de parrilla costal. Resultados: Paciente masculino de 58 años, con un año de dolor costal, asociado a aumento de volumen a nivel de la octava costilla derecha en línea media axilar, indurada. TC de tórax que demuestra imagen sugerente de plasmocitoma de 79 × 44 mm. Se realiza resección quirúrgica, con instalación de malla de prolene en el defecto. Biopsia diferida con compromiso neoplásico por lesión monoclonal de células plasmáticas. Se complementa estudio con biopsia de médula ósea confirmando mieloma múltiple. Se inicia tratamiento con quimioterapia adyuvante. Conclusiones: El plasmocitoma óseo solitario es una entidad de baja frecuencia, que se asocia a la presencia de mieloma múltiple. Es por esto que al momento de la sospecha se hace necesario descartar su presencia, con el fin de mejorar el pronóstico del paciente.


Introduction: Up to 50% of chest wall tumors are malignant; among which rib plasmocytoma stand out. Aim: Showcase a clinical case that debuted as a rib plasmacytoma, and that ended up presenting as Multiple Myeloma. Materials and Method: Records of a patient with resection of chest wall tumor. Results: Male patient of 58 years, with one year of costal pain, associated with an indurated increase in volume at the level of the eighth right rib in the mid-axillary line. Chest CT scan demonstrated a suggestive image of plasmacytoma of 79 × 44 mm. Surgical resection was performed, with prolene mesh installation in the defect. Biopsy showed neoplastic compromise due to monoclonal lesion of plasma cells. Study is complemented with bone marrow biopsy confirming multiple myeloma. The patient was treated with adjuvant chemotherapy. Conclusions: Solitary bone plasmacytoma is a low frequency entity, which is associated with the presence of multiple myeloma. At the moment of suspicion, it is necessary to rule out their presence, in order to improve the patient's prognosis.


Subject(s)
Humans , Male , Middle Aged , Plasmacytoma/surgery , Plasmacytoma/diagnostic imaging , Ribs/pathology , Bone Neoplasms/surgery , Multiple Myeloma/diagnostic imaging , Plasmacytoma/physiopathology , Biopsy , Bone Neoplasms/physiopathology , Bone Neoplasms/diagnostic imaging , Tomography, X-Ray Computed , Chemotherapy, Adjuvant , Multiple Myeloma/physiopathology , Multiple Myeloma/drug therapy
5.
Coluna/Columna ; 17(1): 42-45, Jan.-Mar. 2018. tab, graf
Article in English | LILACS | ID: biblio-890931

ABSTRACT

ABSTRACT Introduction: "Mini brain" image pattern has been identified as a radiological sign for diagnosing multiple myeloma (MM) and solitary plasmacytomas in magnetic resonance imaging (MRI). However, there is still very little data on the frequency with which it can be observed, and its real diagnostic accuracy. Objetive: In this study, we present our case series, discuss sensitivity and specificity of "mini brain" in the diagnosis of multiple myeloma (MM)/plasmacytoma, and conduct a literature review. Methods: The study sample consisted of asymptomatic and/or symptomatic patients consecutively diagnosed with expansive vertebral disease. Patients were evaluated with MRI. A literature review was conducted on the relationship of the radiological sign "mini brain" and the diagnosis of multiple myeloma (MM) or plasmacytoma. Results: Forty-seven patients were evaluated consecutively. Among five patients diagnosed with multiple myeloma, four had an MRI pattern of "mini brain". The sensitivity of "mini brain" was 80%. The specificity was 97.6%. The accuracy was 95.8%. Sensitivity and specificity were 100% when we considered differential diagnoses only with neoplastic lesions involving the spine. Conclusions: "Mini brain" is a feasible and reliable sign for the diagnosis of multiple myeloma /plasmacytoma, guiding physicians for adequate screening and treatment. Nevertheless, it should not replace pathological investigation after vertebral biopsy. Level of Evidence III; Study of case: Case-control study.


RESUMO Introdução . O padrão de imagem ''Mini brain'' foi identificado como um sinal radiológico para diagnosticar mieloma múltiplo e plasmocitomas solitários em ressonância magnética (MR). No entanto, ainda existem dados escassos sobre a frequência na qual ele pode ser observado ea real precisão diagnóstica. Objetivo: No presente estudo, apresentamos nossa série, discutimos a sensibilidade ea especificidade de''mini-brain'' sobre o diagnóstico de mieloma múltiplo (MM)/ plasmocitoma e revisão da literatura. Métodos. A amostra do estudo consistiu de pacientes assintomáticos e/ou sintomáticos consecutivamente diagnosticados com doença vertebral expansiva. Os pacientes foram avaliados com RM. Realizou-se revisão da literatura sobre a relação do sinal radiológico "mini-brain" e o diagnóstico de mieloma múltiplo (MM) ou plamocitoma. Resultados. Quarenta e sete pacientes foram avaliados consecutivamente. Entre os cinco pacientes diagnosticados com mieloma múltiplo, quatro apresentavam padrão MR de "mini-brain". A sensibilidade do "mini-brain" foi de 80%. A especificidade foi de 97,6%. A acurácia foi de 95,8%. A sensibilidade ea especificidade foram de 100%, quando consideramos diagnósticos diferenciais somente com lesões neoplásicas. Conclusão. ''Mini brain'' é um sinal viável e confiável para diagnosticar mieloma múltiplo/plasmocitoma, orientando os médicos para triagem e tratamento adequados. No entanto, não deve substituir a investigação patológica após biópsia vertebral. Nível de Evidência III; Estudo de caso: Estudo caso-controle.


RESUMEN Introducción: Se ha identificado un patrón de imagen ''mini brain'' como una señal radiológica para el diagnóstico de mieloma múltiple (MM) y plasmocitomas solitarios en resonancia magnética (RM). Sin embargo, todavía los datos sobre la frecuencia con la que se puede observar y su exactitud diagnóstica real son escasos. Objetivo: En el presente estudio, presentamos nuestra serie de casos, discutimos la sensibilidad y la especificidad del "mini brain" en el diagnóstico de mieloma múltiple/plasmocitoma y revisamos la literatura. Métodos: La muestra del estudio consistió en pacientes asintomáticos y/o sintomáticos consecutivamente diagnosticados con enfermedad vertebral expansiva. Los pacientes fueron evaluados con RM. Se realizó una revisión de la literatura sobre la relación entre la señal radiológica "mini brain" y el diagnóstico de mieloma múltiple o plasmocitoma. Resultados: Cuarenta y siete pacientes fueron evaluados consecutivamente. Entre los cinco pacientes diagnosticados con mieloma múltiple, cuatro tenían un patrón de resonancia magnética de "mini brain". La sensibilidad del "mini brain" fue del 80%. La especificidad fue 97,6%. La precisión fue 95,8%. La sensibilidad y la especificidad fueron del 100% cuando consideramos diagnósticos diferenciales únicamente con lesiones neoplásicas que afectan a la columna vertebral. Conclusiones: El ''mini brain '' es una señal factible y confiable para diagnosticar mieloma múltiple/plasmocitoma, que guía a los médicos para detección y tratamiento adecuados. Sin embargo, no debería reemplazar la investigación patológica después de la biopsia vertebral. Nivel de Evidencia III; Tipo de Estudio: Estudio de caso control.


Subject(s)
Humans , Plasmacytoma/diagnostic imaging , Multiple Myeloma/diagnostic imaging , Magnetic Resonance Spectroscopy , Sensitivity and Specificity
6.
Rev. méd. Chile ; 145(6): 812-815, June 2017. graf
Article in Spanish | LILACS | ID: biblio-902550

ABSTRACT

Solitary extramedullary plasmacytomas represent 3% of plasma cell neoplasms. Their most common locations are the upper gastrointestinal and respiratory tract. We report a 70-year-old male presenting with progressive dyspnea and cough. A chest radiography showed widened mediastinum. Chest computed tomography showed a mediastinal mass. A bronchoscopy showed an extrinsic compression and complete occlusion of the primary bronchus. A self-expandable prosthesis was installed in left bronchus. A population of plasmacytoid cells was evidenced in the mass biopsy. Immunohistochemistry revealed CD20+ and CD138+. These tumor cells stained positively for lambda light chains, but negatively for kappa chains. Therefore an extramedullary plasmacytoma was diagnosed. A multiple myeloma was discarded with a normal blood count, serum calcium and creatinine levels. Serum protein electrophoresis had a monoclonal spike, serum IgG was 1963 mg/dl. Bone marrow aspiration had 1% of plasma cells. Bone x-rays were normal. Computed tomographies of the neck, thorax, abdomen and pelvis ruled out other plasmacytomas. Eight cycles of chemotherapy with thalidomide, melphalan and prednisone were indicated, obtaining complete remission of the tumor. The review of the literature shows that mediastinal extramedullary plasmacytomas are extremely rare. They generally appear in men aged between 50 and 60 years. The treatment of choice is radiotherapy, but given the location in the present case, chemotherapy was considered the best option. Recurrence is approximately 10 to 30% and 10% of patients progress to myeloma, thus requiring close monitoring.


Subject(s)
Humans , Male , Aged , Plasmacytoma/drug therapy , Plasmacytoma/diagnostic imaging , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Mediastinal Neoplasms/drug therapy , Mediastinal Neoplasms/diagnostic imaging , Thalidomide/therapeutic use , Prednisone/therapeutic use , Tomography , Treatment Outcome , Mediastinoscopy , Melphalan/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL